Dafna Capital Management LLC Ideaya Biosciences, Inc. Transaction History

Dafna Capital Management LLC

$390 Million
Q2 2024

A detailed history of Dafna Capital Management LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 422,213 shares of IDYA stock, worth $13 Million. This represents 3.8% of its overall portfolio holdings.

Number of Shares

422,213

Previous 446,341 5.41%

Holding current value

$13 Million

Previous $19.6 Million 24.31%

% of portfolio

3.8%

Previous 4.71%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $829,279 - $1.05 Million	-24,128 Reduced 5.41%	422,213 $14.8 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $2.39 Million - $3.3 Million	-70,000 Reduced 13.56%	446,341 $19.6 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $406,251 - $591,947	16,521 Added 3.31%	516,341 $18.4 Million
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $421,400 - $595,400	20,000 Added 4.17%	499,820 $13.5 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $152,788 - $292,624	11,462 Added 2.45%	479,820 $11.3 Million
Q4 2022 Feb 14, 2023	SELL	$14.47 - $18.17 $1.02 Million - $1.28 Million	-70,203 Reduced 13.04%	468,358 $8.51 Million
Q3 2022 Nov 14, 2022	SELL	$9.24 - $15.79 $92,400 - $157,900	-10,000 Reduced 1.82%	538,561 $8.04 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $484,379 - $811,980	58,500 Added 11.94%	548,561 $7.57 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $335,400 - $720,600	30,000 Added 6.52%	490,061 $5.48 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $2.22 Million - $3.48 Million	128,400 Added 38.71%	460,061 $11.7 Million
Q3 2020 Nov 16, 2020	BUY	$11.22 - $14.46 $3.72 Million - $4.8 Million	331,661 New	331,661 $4.17 Million

Others Institutions Holding IDYA

# of Institutions

206

Shares Held

73.6M

Call Options Held

21.5K

Put Options Held

20.3K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.48B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Ideaya Biosciences, Inc. Transaction History